Metronidazole reasonable treatment option for patients with symptomatic oral lichen planus
USA: A recent study published in Clinical and Experimental Dermatology has shown metronidazole to be a reasonable option for patients with symptomatic oral lichen planus (OLP) who have failed topical treatment options.
The researchers suggested metronidazole to be a reasonable option given its efficacy, mild side effect profile, and less immunosuppressive nature as compared to alternative systemic treatment options.
At least partial response was seen in 60.0% of the patients treated with metronidazole 500 mg twice daily, with complete response noted in 33.3% of the patients.
Lichen planus is an inflammatory dermatosis with mucosal variants, including oral lichen planus. OLP has relapsing chronic courses and may have a significant impact on quality of life. Following approval from the FDA's Institutional Review Board (IRB), Alison N Hollis, University of North Carolina at Chapel Hill, North Carolina, USA, and colleagues analyzed metronidazole's efficacy as a treatment for oral lichen planus by retrospective chart review of patients at the institution over 10 years with a diagnosis of OLP. The study included patients with concomitant use of topical treatments.
Thirty patients with oral lichen planus were treated with metronidazole 500 mg twice daily. Most patients (n=18, 60.0%) showed improvement with metronidazole, including 10 (33.3%) with complete resolution of symptoms.
The results are limited by the nature of a retrospective review study with a relatively small cohort treated with metronidazole.
Despite multiple limitations of the study, the researchers conclude, "oral metronidazole may be a relatively well-tolerated treatment option for patients with OLP who have failed treatment with first-line topical corticosteroids."
"Given the mild side effect profile, efficacy, and the less immunosuppressive nature of metronidazole compared to alternative systemic treatment options, metronidazole is a reasonable option to try in patients with symptomatic oral lichen planus who have failed topical treatment options," they wrote.
Reference:
Hollis, A. N., Myers, E. L., & Culton, D. A. A retrospective cohort study on the efficacy of metronidazole in oral lichen planus. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad268
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.